Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 24, 2012Organic Process Research & Development

Process Development and Large-Scale Synthesis of MK-6186, a Non-Nucleoside Reverse Transcriptase Inhibitor for the Treatment of HIV

View Full Paper
Ask AI
Bookmark
Share

Authors

AGAdrian GoodyearXLXin LinghuBBBrian Bishop

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Goodyear et al. (2012) studied this question.

synapsesocial.com/papers/6a8bb0e1fe910689a2893944https://doi.org/10.1021/op200334x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Recent Advances in the Development of Next Generation Non-nucleoside Reverse Transcriptase Inhibitors2004 · 45 citations
  2. 2Hydrazones and Azines of Diaryl Ketones1950 · 53 citations
  3. 3Design and Synthesis of Conformationally Constrained Inhibitors of Non-Nucleoside Reverse Transcriptase2011 · 41 citations
  4. 4Palladium-Catalyzed Amination of Aryl Halides: Mechanism and Rational Catalyst Design1997 · 298 citations
  5. 5Control of Genotoxic Impurities in Active Pharmaceutical Ingredients: A Review and Perspective2010 · 128 citations